Yu-Feng Li

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Squamous Cell Carcinoma

Tyrosine Kinase

Acute Kidney Injury

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Zhou, Guo-Hong Zheng, Na Li, Jing-Jing Liu, Xiao-Hong Wang, Yu-Feng Li
Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report. Immunotherapy (2023)
Yang Zhou, Guo-Hong Zheng, Na Li, Jing-Jing Liu, Xiao-Hong Wang, Yu-Feng Li
Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report. Immunotherapy 15 (9) (2023)
Yang Zhou, Guo-Hong Zheng, Na Li, Jing-Jing Liu, Xiao-Hong Wang, Yu-Feng Li
Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report. Immunotherapy 15 (9) (2023)
Yang Zhou, Guo-Hong Zheng, Na Li, Jing-Jing Liu, Xiao-Hong Wang, Yu-Feng Li
Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report. Immunotherapy 15 (9) (2023)
Yan Liu, Yuan-Yue Zhang, Shu-Qing Wang, Min Li, Yue-Hong Long, Yu-Feng Li, Yan-Kun Liu, Yu-Hui Li, Ya-Qi Wang, Jiang-Sheng Mi, Cheng-Hua Yu, De-Yan Li, Jing Hua Zhang, Xiao-Jun Zhang
WSTF acetylation by MOF promotes WSTF activities and oncogenic functions. Oncogene 39 (27) (2020)